Search

everythinglearnresearchcommunity

for

Search:↓

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.

Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

PRP injections improve hair density and thickness in women with hair loss.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

Finasteride shows promise for female hair loss, but more research needed.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Hair follicle culture helps develop new treatments for hair loss.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

PRP injections improve hair density and thickness in women with hair loss.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

Combination therapies work better than single treatments for hair loss.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

BeauTop improves hair growth in androgenetic alopecia patients.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Thread monofilament and minoxidil together increase hair growth in female androgenetic alopecia.

As people get older, they have less active hair growth, but women have thicker hair than men and respond better to hair loss treatments.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

People distressed by minor skin changes should consult dermatologists with cosmetic expertise, and a public Cosmetic Dermatology Service with mental health support is recommended.

MSC-derived EVs have potential as therapeutic agents but face challenges like production complexity and high costs.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Pharmacists play a crucial role in health literacy and patient care.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Intradermotherapy with minoxidil is as effective as topical application for treating hair loss.